NVCR
NovoCure Ltd

7,372
Mkt Cap
$1.17B
Volume
369,412.00
52W High
$22.95
52W Low
$9.82
PE Ratio
-6.50
NVCR Fundamentals
Price
$10.36
Prev Close
$10.47
Open
$10.50
50D MA
$12.82
Beta
1.43
Avg. Volume
1.2M
EPS (Annual)
-$1.56
P/B
3.43
Rev/Employee
$406,733.87
$2,934.60
Loading...
Loading...
News
all
press releases
NovoCure Limited (NASDAQ:NVCR) Receives Consensus Rating of "Hold" from Analysts
Shares of NovoCure Limited (NASDAQ:NVCR - Get Free Report) have earned an average recommendation of "Hold" from the seven ratings firms that are currently covering the company, Marketbeat.com...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
HC Wainwright Has Bearish Forecast for NovoCure Q1 Earnings
NovoCure Limited (NASDAQ:NVCR - Free Report) - Equities researchers at HC Wainwright cut their Q1 2026 earnings per share (EPS) estimates for NovoCure in a report released on Thursday, February 5th...
MarketBeat·3d ago
News Placeholder
HC Wainwright Has Negative View of NovoCure FY2029 Earnings
NovoCure Limited (NASDAQ:NVCR - Free Report) - HC Wainwright decreased their FY2029 earnings per share (EPS) estimates for shares of NovoCure in a report released on Thursday, February 5th. HC...
MarketBeat·5d ago
News Placeholder
C WorldWide Group Holding A S Grows Position in NovoCure Limited $NVCR
C WorldWide Group Holding A S grew its position in NovoCure Limited (NASDAQ:NVCR - Free Report) by 56.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·5d ago
News Placeholder
NovoCure (NASDAQ:NVCR) Sets New 52-Week Low - What's Next?
NovoCure (NASDAQ:NVCR) Reaches New 1-Year Low - What's Next...
MarketBeat·6d ago
News Placeholder
Bristol Myers Squibb (BMY) Tops Q4 Earnings and Revenue Estimates
Bristol Myers (BMY) delivered earnings and revenue surprises of +9.33% and +2.03%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
Hussman Strategic Advisors Inc. Takes $1.09 Million Position in NovoCure Limited $NVCR
Hussman Strategic Advisors Inc. purchased a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The...
MarketBeat·13d ago
News Placeholder
NovoCure Limited (NASDAQ:NVCR) Short Interest Update
NovoCure Limited (NASDAQ:NVCR - Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totaling 8,333,839 shares, an increase of 20.0% from...
MarketBeat·23d ago
News Placeholder
Assessing NovoCure: Insights From 4 Financial Analysts
read more...
Benzinga·27d ago
News Placeholder
NovoCure (NASDAQ:NVCR) Receives Neutral Rating from Wedbush
Wedbush reaffirmed a "neutral" rating and issued a $18.00 price objective on shares of NovoCure in a report on Thursday...
MarketBeat·27d ago
<
1
2
...
>

Latest NVCR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.